What is the Market Size of Clinical Trial Imaging | Key Players & Strategic Developments 2026

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA10639

Publication Date: Nov 2025

What is the size of Clinical Trial Imaging Market?

According to 6Wresearch internal database and industry insights, the Global Clinical Trial Imaging Market was valued at USD 2.7 Billion in 2025 and is expected to reach USD 4.2 Billion by 2032, growing at a compound annual growth rate of 6% during the forecast period (2026-2032).

The main drivers of this growth are the increasing reliance on advanced imaging endpoints in drug development, researchers’ shift towards precision-based trial designs, and the rising adoption of imaging biomarkers to improve trial efficiency and outcome clarity.

For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Global Clinical Trial Imaging Market.

View Main Report Schedule Analyst Call

Growth Factors for Clinical Trial Imaging Industry

Growing interest in imaging-based biomarkers as substitutes for conventional clinical endpoints in trials.
Rising demand for services from biotechnology and pharmaceutical companies to expedite development pipelines.
Escalating adoption of AI and analytics among imaging service providers to enhance data quality and decision making.
Expanding partnerships between imaging core labs and contract research organisations to streamline trial workflows.
Innovation in imaging modalities and integrated service platforms tailored for clinical-trial environments.

Clinical Trial Imaging Market Trends

The Clinical Trial Imaging market trends indicate a shift toward comprehensive imaging service offerings that combine modalities such as CT, MRI, PET and ultrasound with cloud-based analytics platforms. There is rising uptake of centralised imaging labs and virtual monitoring to meet the complex needs of multi-site trials and therapy areas such as oncology and neurology. Outsourcing of imaging services to specialist providers continues to grow, supported by heightened regulatory focus on standardisation and reproducibility of imaging endpoints.

Emerging Developments in the Clinical Trial Imaging Market

The Clinical Trial Imaging market developments reflect increased deployment of hybrid trial models incorporating remote imaging data capture, the emergence of imaging-AI collaborations to accelerate interpretation and endpoint read-outs, and expansion of modalities such as functional MRI and molecular PET in late-phase studies. Imaging service providers are also entering Asia Pacific markets and forming strategic alliances with CROs to meet increasing demand from regional trial hubs.